Sydney Morning Herald
AsiaPac · 1 hrs ago
Amplia eyes major role in new cancer drug frontier
—Quality
0Ratings
0Comments
Amplia eyes major role in new cancer drug frontier
Amplia Therapeutics is positioning its “shield-breaker” cancer drug as a key partner for a new class of kRAS inhibitors, a major theme at a recent global oncology conference.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!